Pure Global
NCT05250102

Neonatal Pulse Oximetry Sensor Study

Accuracy and Precision of Peripheral Capillary Oxygen Saturation of Reprocessed Pulse Oximetry Sensors Compared to Oxygen Saturation in Arterial Blood Samples Assessed by CO-oximetry in Neonates
Medline Industries·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Premature Birth
Drug/Device/Intervention
Pulse oximeter sensors
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Medline Industries
Location
Los Angeles,Greenville, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 13, 2022
End date
Dec 31, 2023
Enrollment
27 participants
Primary outcome

Pulse oximeter and co-oximeter readings

Summary

To validate the SpO2 accuracy, bias, and precision of Medline's reprocessed pulse oximetry
 sensors as compared to SaO2 in arterial blood samples as assessed by CO-oximetry in neonates.

ICD-10 classifications
Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05250102
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05250102 through Pure Global AI's free database. This phase not specified trial is sponsored by Medline Industries and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 27 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.